Big movements in Genprex Inc. stock price on Tuesday moving 11.81% between high and low
(Updated on Jun 10, 2025)
Buy candidate since Jun 09, 2025 Gain 3.40%
The Genprex Inc. stock price gained 3.40% on the last trading day (Tuesday, 10th Jun 2025), rising from $0.309 to $0.320. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 11.81% from a day low at $0.291 to a day high of $0.326. The price has risen in 6 of the last 10 days and is up by 17.81% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 185 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $425.29 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.41% during the next 3 months and, with a 90% probability hold a price between $0.150 and $0.322 at the end of this 3-month period.
GNPX Signals & Forecast
The Genprex Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.296 and $0.281. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Genprex Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, May 30, 2025, and so far it has fallen -4.28%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Genprex Inc. stock
Genprex Inc. finds support from accumulated volume at $0.310 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0344 between high and low, or 11.81%. For the last week, the stock has had daily average volatility of 12.15%.
Our recommended stop-loss: $0.304 (-4.97%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 7 days ago.)
Trading Expectations (GNPX) For The Upcoming Trading Day Of Wednesday 11th
For the upcoming trading day on Wednesday, 11th we expect Genprex Inc. to open at $0.312, and during the day (based on 14 day Average True Range), to move between $0.282 and $0.357, which gives a possible trading interval of +/-$0.0372 (+/-11.64%) up or down from last closing price. If Genprex Inc. takes out the full calculated possible swing range there will be an estimated 23.28% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.310 (2.97%) than the resistance at $0.333 (4.23%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Insiders are Very Positive Buying More Shares Than They Are Selling In Genprex Inc.
In the last 100 trades there were 14.66 million shares bought and 1.08 million shares sold. The last trade was made 114 days ago by Berger Mark Stanley who sold 585 shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside. In some cases larger purchases can be explained by due date for stock options.
Is Genprex Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term
Comments
$Genprex, Inc.(GNPX)$
Genprex Inc., a clinical-stage gene therapy company, has announced the presentation of positive preclinical research findings on its diabetes gene therapy drug candidate, GPX-002, at the 2025 American Diabetes Association 85th Scientific Sessions in Chicago. The research demonstrated that GPX-002 aids in the transdifferentiation of alpha cells into beta-like cells, leading to improved glucose homeostasis in animal models of Type 1 diabetes. The study, presented by Dr. Hannah Rinehardt, utilized recombinant adeno-associated virus (rAAV) to deliver the Pdx1 and MafA genes into the pancreatic duct, reversing diabetes without the need for immunosuppression in mouse models. Current preclinical studies are ongoing in non-human primate models to further evaluate the therapy's efficacy and immune response management.